Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)
Clinical trial NCT02186496 · COMPLETED
Trial details
- NCT number
- NCT02186496
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2014-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.